Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) reported Q3 EPS of ($0.43), $0.05 worse than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Verrica Pharmaceuticals Inc. (VRCA) click here.